Rxo Net Debt Growth & History (RXO)
Rxo's net debt was $653.0M for fiscal 2025.
View full Rxo company overviewRxo annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $653.0M | $24.0M | +3.82% |
| 2024 | 2024-12-31 | $629.0M | $76.0M | +13.74% |
| 2023 | 2023-12-31 | $553.0M | $34.0M | +6.55% |
| 2022 | 2022-12-31 | $519.0M | $413.0M | +389.62% |
| 2021 | 2021-12-31 | $106.0M | — | — |
Rxo quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $713.0M | $52.0M | +7.87% |
| Q1 2026 | 2026-03-31 | $678.0M | $9.0M | +1.35% |
| Q4 2025 | 2025-12-31 | $653.0M | $24.0M | +3.82% |
| Q3 2025 | 2025-09-30 | $657.0M | $9.0M | +1.39% |
| Q2 2025 | 2025-06-30 | $661.0M | $68.0M | +11.47% |
| Q1 2025 | 2025-03-31 | $669.0M | $105.0M | +18.62% |
| Q4 2024 | 2024-12-31 | $629.0M | $76.0M | +13.74% |
| Q3 2024 | 2024-09-30 | $648.0M | $123.0M | +23.43% |
| Q2 2024 | 2024-06-30 | $593.0M | $96.0M | +19.32% |
| Q1 2024 | 2024-03-31 | $564.0M | $75.0M | +15.34% |
| Q4 2023 | 2023-12-31 | $553.0M | $34.0M | +6.55% |
| Q3 2023 | 2023-09-30 | $525.0M | $540.0M | — |
| Q2 2023 | 2023-06-30 | $497.0M | — | — |
| Q1 2023 | 2023-03-31 | $489.0M | — | — |
| Q4 2022 | 2022-12-31 | $519.0M | $413.0M | +389.62% |
| Q3 2022 | 2022-09-30 | −$15.0M | — | — |
| Q4 2021 | 2021-12-31 | $106.0M | — | — |
Rxo net debt trends
Between the periods ended 2021-12-31 and 2025-12-31, Rxo's net debt increased from $106.0M to $653.0M, a change of $547.0M. The latest reported quarter, Q2 2026, shows $713.0M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Rxo source filings ↗